Global Pseudomonas Aeruginosa Infection Treatment Market Research Report 2024
January 29, 2024 09:35 ET
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Pseudomonas Aeruginosa Infection Treatment Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. As the healthcare...
Global Hepatitis Therapeutics Market On The Rise: Projected Growth of USD 18.8 Billion By 2030 with North America Leading the Way
January 24, 2024 06:12 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Hepatitis Therapeutics Market 2030 by Hepatitis Type, Drug Class, Drug Type, End-user and Distribution Channel and Region - Partner &...
Global Hepatitis B Tests Market Forecasts to 2033: In-Depth Analysis of Segments, Regulatory Landscape, and Emerging Trends
January 23, 2024 11:23 ET
|
Research and Markets
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Hepatitis B Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033" report has been added to ResearchAndMarkets.com's...
Global Pseudomonas Aeruginosa Infection Treatment Market Report 2024: A USD 4.07 Billion Market by 2034, with Novel Antibiotics and Combination Therapies Emerging
January 22, 2024 05:18 ET
|
Research and Markets
Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The "Global Pseudomonas Aeruginosa Infection Treatment Market" report has been added to ResearchAndMarkets.com's offering. The global pseudomonas...
Global COVID-19 Nucleic Acid Amplification Tests (NAATs) Clinical Pipeline Research Report 2023: Stages of Development, Segments, Region and Countries, Regulatory Path and Competitive Landscape
January 16, 2024 13:08 ET
|
Research and Markets
Dublin, Jan. 16, 2024 (GLOBE NEWSWIRE) -- The "COVID-19 Nucleic Acid Amplification Tests (NAATs) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and...
United States LOTEMAX SM (Loteprednol Etabonate Ophthalmic Gel) Drug Insights and Market Forecasts Report, 2019-2022 and 2023-2032
December 14, 2023 10:38 ET
|
Research and Markets
Dublin, Dec. 14, 2023 (GLOBE NEWSWIRE) -- The "LOTEMAX SM Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
REBYOTA (RBX2660) Drug Insight and Market Forecasts, 2032: Focus on United States, Germany, France, Italy, Spain United Kingdom, and Japan
December 14, 2023 10:33 ET
|
Research and Markets
Dublin, Dec. 14, 2023 (GLOBE NEWSWIRE) -- The "REBYOTA Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
SER-109: A Potential First-in-Class Investigational Oral Microbiome Therapeutic Designed to Reduce the Recurrence of CDI - Drug Insights and Market Forecasts to 2032
December 13, 2023 04:13 ET
|
Research and Markets
Dublin, Dec. 13, 2023 (GLOBE NEWSWIRE) -- The "SER-109 Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
Chronic Hepatitis B Market Forecast to 2032: Significant Growth Expected with USD 1,500 Million in US 7MM and Emerging Therapies Uptake
December 11, 2023 08:38 ET
|
Research and Markets
Dublin, Dec. 11, 2023 (GLOBE NEWSWIRE) -- The "Chronic Hepatitis B - Market Insight, Epidemiology And Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. Global...
Hepatitis C Tests Market Size, Regulatory and Reimbursement Landscape, Procedures and Forecast to 2033
November 28, 2023 04:43 ET
|
Research and Markets
Dublin, Nov. 28, 2023 (GLOBE NEWSWIRE) -- The "Hepatitis C Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and...